Key result
Colchicine for pericarditis is linked to recurrent neuromyopathy as an underreported side effect.
Why the study?
Neuromyopathy is a recognized but likely underreported side effect of colchicine used for acute and recurrent pericarditis.
Population
A 56-year-old woman with recurrent episodes of colchicine-induced neuromyopathy
Design
Case report
Follow-up
Many years
Authors
Loading...
Clinicians should monitor for recurrent neuromyopathy with prolonged colchicine; this case leaves open true incidence and prevention strategies.
Highlights neuromyopathy as a potentially underreported side effect of colchicine used for pericardial inflammation.
Perzon et al. (2022) studied this question. Colchicine use for pericarditis can cause recurrent episodes of neuromyopathy, a well-known but likely underreported side effect demonstrated in a 56-year-old woman.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: